ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

オキセサゼイン

Oxethazaine

HCID 4621
反応を作成
印刷

データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます

基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
126-27-2
標準SMILES
CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc1ccccc1
InChIKey
FTLDJPRFCGDUFH-UHFFFAOYSA-N
分子式
C28H41N3O3
平均分子量
467.6 g/mol
単同位体質量
467.31479218

概要

Oxethazaine is a white powder. (NTP, 1992)

名称と識別子

優先名称
Oxethazaine
IUPAC
2-[2-hydroxyethyl-[2-[methyl-(2-methyl-1-phenylpropan-2-yl)amino]-2-oxoethyl]amino]-N-methyl-N-(2-methyl-1-phenylpropan-2-yl)acetamide
現地名
オキセサゼイン
英語名
Oxethazaine
分子式
C28H41N3O3
分子量
467.64

名称と別名

Oxethazaine126-27-2OxetacaineOxethacaineOxaineMuthesaStrocainOxetacainaoxethazineOxetacainumWy-806WY 806
名称をさらに表示
オキセサゼインオキセタカインオキセタザインオキセサゼイン (JP17)ムコキシン3-[6-ヒドロキシ-6-[5′-(1-ヒドロキシオクタデシル)-3′-ヒドロキシ-2,2′-ビオキソラン-5-イル]ヘキシル]-5α-メチルフラン-2(5H)-オン(5S)-3-{6-ヒドロキシ-6-[3'-ヒドロキシ-5'-(1-ヒドロキシオクタデシル)-[2,2'-ビオキソラン]-5-イル]ヘキシル}-5-メチル-2,5-ジヒドロフラン-2-オンfh099C12552mutesatepiltamucainemucoxin
DTXSID0025818Acetamide, 2,2'-((2-hydroxyethyl)imino)bis(N-(1,1-dimethyl-2-phenylethyl)-N-methyl-FH 099NSC-758444IP8QT76V17Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl-DTXCID6058182-Di(N-methyl-N-phenyl-tert-butyl-carbamoylmethyl)aminoethanol

データベース識別子

CAS
126-27-2
PubChem CID
4621
DTXSID
DTXSID0025818
ChEMBL

物性

構造計算による物性補完中

XLogP
3.8
極性表面積
64.1 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
12
重原子数
34
形式電荷
0
複雑度
585

実験および物理化学的性質

Drugs · 2 件

Pharmaceuticals -> Listed in ZINC15

Pharmaceuticals

Solubility · 2 件

less than 1 mg/mL at 73 °F (NTP, 1992)

<0.1 g/100 ml at 23 ºC

Human DrugsPharmaceuticals
Melting Point · 2 件

219 to 220 °F (NTP, 1992)

100-101 ºC

Physical DescriptionOxethazaine is a white powder. (NTP, 1992)
Dissociation Constants6.25
Collision Cross Section · 2 件

215.22 Ų [M+Na]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

213.7 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
104 · 104-105°C
沸点
570.1 °C · 570.1°C (rough estimate)
比重(密度)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 40 reports by companies from 1 notifications to the ECHA C&L Inventory.

危険有害性情報

Other Safety InformationIMAP assessments - Acetamide, 2,2'-[(2-hydroxyethyl)imino]bis[N-(1,1-dimethyl-2-phenylethyl)-N-methyl]-: Environment tier I assessment
Fire HazardsFlash point data are not available for this chemical, but it is probably combustible. (NTP, 1992)
Reactive GroupAlcohols and Polyols
Reactivity Profile · 1 件

A hydroxylated amide. Organic amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

Air and Water ReactionsInsoluble in water.
Hazard Classes and CategoriesAcute Tox. 4 (100%)

安全と保護具

Fire FightingFires involving this compound should be controlled with a dry chemical, carbon dioxide or Halon extinguisher. (NTP, 1992)

化学と産業

薬理情報

ATC Code · 2 件

C - Cardiovascular system

QC - Cardiovascular system

Protein BindingDue to the low half-life, it is thought that oxetacaine, when absorbed, presents a very low protein plasma binding.
Pharmacodynamics · 1 件

Oxetacaine improves common gastrointestinal symptoms. Oxetacaine is part of the anesthetic antacids which increase the gastric pH while providing relief from pain for a longer period of duration at a lower dosage. This property has been reported to relieve the symptoms of hyperacidity. Oxetacaine is reported to produce a reversible loss of sensation and to provide a prompt and prolonged relief of pain. In vitro, oxetacaine was showed to produce an antispasmodic action on the smooth muscle and block the action of serotonin. The local efficacy of oxetacaine has been proven to be 2000 times more potent than lignocaine and 500 times more potent than cocaine. Its anesthetic action produces the loss of sensation which can be explained by its inhibitory activity against the nerve impulses and de decrease in permeability of the cell membrane.

Mechanism of Action · 1 件

Oxetacaine inhibits gastric acid secretion by suppressing gastrin secretion. Moreover, oxetacaine exerts a local anesthetic effect on the gastric mucosa. This potent local anesthetic effect of oxetacaine may be explained by its unique chemical characteristics in which, as a weak base, it is relatively non-ionized in acidic solutions whereas its hydrochloride salt is soluble in organic solvents and it can penetrate cell membranes. Oxetacaine diminishes the conduction of sensory nerve impulses near the application site which in order reduces the permeability of the cell membrane to sodium ions. This activity is performed by the incorporation of the unionized form into the cell membrane.

Biological Half-LifeOxetacaine presents a very short half-life of approximately one hour.
Metabolism/Metabolites · 1 件

Oxetacaine is rapidly and extensively metabolized hepatically. After metabolism, there is a formation of primary metabolites such as beta-hydroxy-mephentermine and beta-hydroxy-phentermine. The major metabolites are found in the plasma in insignificant amounts.

関連反応

0 件
反応記録を作成
関連する反応はまだありません

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
CHEMBL127592
ChEBI
CHEBI:31947
UNII
IP8QT76V17
EC Number
204-780-5
Nikkaji
J2.510K
1.0974 · 1.0974 (rough estimate)
屈折率
1.78 · 1.7800 (estimate)
貯蔵温度
Refrigerator
溶解性
水にほとんど溶けません。メタノールに溶けやすい。酢酸エチルに溶ける。
酸解離定数(Pka)
14.62 · 14.62±0.10(Predicted)
外見
Solid
色
ホワイトからオフホワイト
水溶解度
0.1 g/100 · <0.1 g/100 mL で 23 ºC
主な用途
法医学と毒物学医薬品(低分子化合物)獣医
InChI
1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3
InChIKey
FTLDJPRFCGDUFH-UHFFFAOYSA-N
SMILES
CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc2ccccc2
CAS データベース
126 · 126-27-2(CAS DataBase Reference)
EPAの化学物質情報
Oxethazaine (126-27-2)

化学的性質

化学的特性White Solid

First Aid · 1 件

EYES: First check the victim for contact lenses and remove if present. Flush victim's eyes with water or normal saline solution for 20 to 30 minutes while simultaneously calling a hospital or poison control center. Do not put any ointments, oils, or medication in the victim's eyes without specific instructions from a physician. IMMEDIATELY transport the victim after flushing eyes to a hospital even if no symptoms (such as redness or irritation) develop.

Nonfire Spill Response · 1 件

SMALL SPILLS AND LEAKAGE: You should dampen the solid spill material with acetone, then transfer the dampened material to a suitable container. Use absorbent paper dampened with acetone to pick up any remaining material. Seal your contaminated clothing and the adsorbent paper in a vapor-tight plastic bag for eventual disposal. Solvent wash all contaminated surfaces with acetone followed by washing with a strong soap and water solution. Do not reenter the contaminate area until the Safety Officer (or other responsible person) has verified that the area has been properly cleaned.

Personal Protective Equipment (PPE) · 1 件

RECOMMENDED RESPIRATOR: Where the neat test chemical is weighed and diluted, wear a NIOSH-approved half face respirator equipped with an organic vapor/acid gas cartridge (specific for organic vapors, HCl, acid gas and SO2) with a dust/mist filter. (NTP, 1992)

安全データ

wgk
3
rtecs
AC3325000
毒性
LD50 oral in rat: 1gm/kg
risk_code
22
hazard_code
Xn
safety_code
36
Hazard Classifications
Acute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids
MeSH Pharmacological Classification · 1 件

Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate.

Absorption, Distribution and Excretion · 4 件

A peak plasma concentration of oxetacaine of approximately 20 ng/ml is attained about one hour after oral administration. LEss than 1/3 of the administered dose is absorbed as it undergoes extensive metabolism.

Less than 0.1% of the amdinistered dose is recovered in urine within 24 hours in the form of unchanged oxetacaine or its metabolites.

This pharmacokinetic property has not been studied.

This pharmacokinetic property has not been studied.

用途と製造

UsesUse (kg; approx.) in Germany (2009): >50
Use ClassificationPharmaceuticals
応用分野 · 4 件

用途ガストリン分泌抑制作用を示 します。

用途ガストリン分泌抑制作用を示 します。

使用A potent local anesthetic that is active even in acidic conditions. It is used (usually in combination with an antacid) for the relief of pain associated with peptic ulcer disease or esophagitis.

一般的な説明White powder.

上流・下流製品情報

上流原料

2-アミノエタノール